ESRP1 and breast cancer: Furthermore, a recent study by Wang et al. demonstrated that stiff matrix promotes the intravasation of breast cancer cells through the decreased ESRP1-mediated alternative splicing of MENA, indicating that ESRP1 decreases breast cancer cell intravasation [56].